Trial Profile

A phase III study of E7777 in patients with cutaneous T-cell lymphoma.

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 16 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Denileukin diftitox (Primary)
Indications Cutaneous T-cell lymphoma
Focus Registrational; Therapeutic Use

Most Recent Events

15 Sep 2022 According to a Citius Pharmaceuticals media release, BLA submission is being prepared for the second half of 2022.
15 Feb 2022 Status changed from planning to recruiting as per Citius Pharmaceuticals media release.
05 Apr 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com